Page last updated: 2024-12-04

3-aminopropionaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-aminopropionaldehyde: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-aminopropanal : A propanal having an amino substituent at the 3-position [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID75
CHEBI ID18090
CHEBI ID27390
MeSH IDM0145003

Synonyms (18)

Synonym
unii-ml707y407u
ml707y407u ,
propanal, 3-amino-
352-92-1
CHEBI:18090
3-aminopropionaldehyde
beta-aminopropion aldehyde
C05665
3-aminopropanal
AKOS006341697
propanal, 3-amino-(9ci)
.beta.-aminopropionaldehyde
PCXDJQZLDDHMGX-UHFFFAOYSA-N
DTXSID10188702
omega-aminoaldehydes
CHEBI:27390
Q22984448
EN300-1692762
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
propanalsAn aldehyde based on a propanal skeleton and its derivatives.
omega-aminoaldehydeAn amino aldehyde that is an aliphatic aldehyde in which one of the hydrogens of the terminal methyl group has been replaced by an amino group. H2NCH2(CH2)nCHO, where n = 0, 1, 2, etc.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (15)

PathwayProteinsCompounds
Metabolism14961108
Amino acid and derivative metabolism250260
Metabolism of polyamines5621
Interconversion of polyamines313
Biological oxidations150276
Phase I - Functionalization of compounds69175
Amine Oxidase reactions419
PAOs oxidise polyamines to amines211
beta-Alanine Metabolism927
GABA-Transaminase Deficiency927
Ureidopropionase Deficiency927
Carnosinuria, Carnosinemia927
polyamine degradation (oxidative deamination pathway)08
Beta-alanine biosynthesis04
Beta-alanine biosynthesis I312

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (12.00)18.7374
1990's3 (12.00)18.2507
2000's10 (40.00)29.6817
2010's7 (28.00)24.3611
2020's2 (8.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.58 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (92.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]